DV
Dividend Vision

HRGN — Harvard Apparatus Regenerative Technology Inc.

Harvard Apparatus Regenerative Technology Inc. (HRGN)

Total return is -98.8% over the past 12.8 years, 551.2 points behind SPY at 452.4%. Its deepest 1-year drawdown was 55.0%.

HRGN is an equity fund focused on technology stocks that was established in 2013. The fund does not currently distribute dividends to shareholders. With limited publicly available data on expense ratios and assets under management, this fund may appeal primarily to growth-oriented investors rather than those seeking income through regular distributions.

HRGN key facts

Asset type
Stock
Asset class
Equity
Inception date
10/21/2013
Distribution frequency
None
Last close
$1.40
Market cap
$24,613,042
Average volume
828.0
Beta
-0.348
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.41